Clinical Risk Factors for Primary Graft Failure Following Lung Transplantation
Overview
Authors
Affiliations
Study Objective: s: Primary graft failure (PGF) is a devastating acute lung injury syndrome following lung transplantation. We sought to identify donor, recipient, and operative risk factors for its development.
Design: We conducted a cohort study of 255 consecutive lung transplant procedures performed between October 1991 and July 2000. We defined PGF as follows: (1) diffuse alveolar opacities exclusively involving allograft(s) and developing within 72 h of transplant, (2) a ratio of PaO(2) to fraction of inspired oxygen < 200 beyond 48 h postoperatively, and (3) no other secondary cause of graft dysfunction identified. Risk factors were assessed individually and adjusted for confounding using multivariable logistic regression models.
Setting: Tertiary-care academic medical center.
Results: The overall incidence was 11.8% (95% confidence interval [CI], 7.9 to 15.9). Following multivariable analysis, the risk factors independently associated with development of PGF were as follows: a recipient diagnosis of primary pulmonary hypertension (PPH; adjusted odds ratio [OR], 4.52; 95% CI, 1.29 to 15.9; p = 0.018), donor female gender (adjusted OR, 4.11; 95% CI, 1.17 to 14.4; p = 0.027), donor African-American race (adjusted OR, 5.56; 95% CI, 1.57 to 19.8; p = 0.008), and donor age < 21 years (adjusted OR, 4.06; 95% CI, 1.34 to 12.3; p = 0.013) and > 45 years (adjusted OR, 6.79; 95% CI, 1.61 to 28.5; p = 0.009).
Conclusions: Recipient diagnosis of PPH, donor African-American race, donor female gender, and donor age are independently and strongly associated with development of PGF.
Kurihara C, Kaiho T, Thomae B, Cerier E, Lung K, Avella Patino D J Thorac Dis. 2024; 16(8):5050-5062.
PMID: 39268121 PMC: 11388248. DOI: 10.21037/jtd-24-100.
Analysis of Primary Graft Dysfunction (PGD) Risk Factors in Lung Transplantation (LuTx) Patients.
Kubisa M, Wojtys M, Lisowski P, Kordykiewicz D, Piotrowska M, Wojcik J Clin Pract. 2024; 14(4):1571-1583.
PMID: 39194931 PMC: 11352894. DOI: 10.3390/clinpract14040127.
Di Y, Fu R, Xiang Z, Sun H, Dai M, Zhang Q Ann Thorac Cardiovasc Surg. 2024; 30(1).
PMID: 39111865 PMC: 11324350. DOI: 10.5761/atcs.ra.24-00092.
Jenkins J, Verdiner R, Omar A, Farina J, Wilson R, DCunha J Front Immunol. 2024; 15:1341675.
PMID: 38380332 PMC: 10876853. DOI: 10.3389/fimmu.2024.1341675.
Male versus female inflammatory response after brain death model followed by ex vivo lung perfusion.
Ricardo-da-Silva F, Armstrong-Jr R, de Assis Ramos M, Vidal-Dos-Santos M, Correia C, Ottens P Biol Sex Differ. 2024; 15(1):11.
PMID: 38287395 PMC: 10826050. DOI: 10.1186/s13293-024-00581-8.